HK Stock Market Move | MeiG Smart Technology (03268) rose more than 6%, officially launched the MeiG MIND aggregation platform, efficiently empowering the large-scale landing of AI applications in multiple scenarios and terminals.
Megvii Technology (03268) rose more than 6%, as of the time of writing, up 6.1% to HK$18.27, with a turnover of HK$30.822 million.
MeiG Smart Technology (03268) rose more than 6%, with a 6.1% increase as of the time of publication, reaching HK$18.27, with a trading volume of HK$30.822 million.
On the news front, according to an official announcement from MeiG Smart Technology, at the 2026 World Artificial Intelligence Conference, MeiG Smart Technology officially launched its self-developed AI model network and performance data visualization dashboard platform - MeiG MIND, efficiently empowering the large-scale deployment of AI applications in various scenarios. This platform not only breaks the "black box" of model selection with massive actual test data, but also uses MeiG's self-developed AI engine and MOJO toolchain as the technical foundation to seamlessly connect module computing power, model performance, model resource download, and engineering deployment.
According to the introduction, the most core value of the MeiG MIND platform lies in the comprehensive opening of MeiG Smart Technology's years of accumulated experience in adapting AI on the edge and actual test data. MeiG MIND relies on MeiG Smart Technology's independently developed MEIGINE AI inference engine, conducting deep operator adaptation and instruction-level optimization for AI modules on more than ten different chip platforms (including SNM983, SNM982, SRM975, SRM965, etc.). This has resulted in the platform including over 184 mainstream AI models, over 1800 cross-platform actual performance reports, all based on real operating results of the modules, rather than simulated estimates.
Related Articles

JUNSHI BIO (01877): The supplemental application for the use of Tropil Single Top Antibody in combination with chemotherapy for adjuvant therapy in patients with resectable stage II-III non-small cell lung cancer has been accepted.

Market volatility + Tesla's public listing attracts retail investors! Trading frenzy boosts Charles Schwab Corp (SCHW.US) Q2 earnings beyond expectations.

Shenzhen Energy Group (000027.SZ) intends to invest in the construction of the 50MW solar power project in Ghana, Natamale.
JUNSHI BIO (01877): The supplemental application for the use of Tropil Single Top Antibody in combination with chemotherapy for adjuvant therapy in patients with resectable stage II-III non-small cell lung cancer has been accepted.

Market volatility + Tesla's public listing attracts retail investors! Trading frenzy boosts Charles Schwab Corp (SCHW.US) Q2 earnings beyond expectations.

Shenzhen Energy Group (000027.SZ) intends to invest in the construction of the 50MW solar power project in Ghana, Natamale.

RECOMMEND





